| Expression pattern: |
UP |
| Associated gene: |
POLRMT, TIMM50 |
| Associated microRNA: |
- |
| Biological function: |
promotes cardiac remodelling and heart failure phenotypes; decreases heart function; promotes fibrosis |
| Molecular mechanism: |
circRNA translation into SLC8a1-604; SLC8a1-604 translocates to mitochondria and binds POLRMT (with TIMM50), downregulating mitochondrial gene transcription and reducing ATP synthesis |
| Biological pathway or process: |
mitochondrial function (inhibits); oxidative phosphorylation (inhibits); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Western Blot; Nuclear-Cytoplasmic Fractionation; Transfection; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; Luciferase Reporter Assay; Bioinformatics Analysis; RNA-seq; Clinical Sample Validation; In Vivo Animal Model; FISH / smFISH; ISH (In Situ Hybridization); IF (Immunofluorescence); ELISA |
| Clinical significance: |
circSLC8a1 is significantly increased in heart failure patients and is suggested as a therapeutic target |
| Description: |
In heart failure/cardiac pressure-overload remodelling, circSLC8a1 is up-regulated and exerts pathogenic effects mainly by being translated into SLC8a1-604. The translated protein interacts with TIMM50 and POLRMT in mitochondria to repress mitochondrial gene transcription and ATP production, contributing to impaired cardiac function and remodelling/fibrosis. |
| Confidence score: |
0.7766 |